Abvc biopharma report updated by zacks/scr

Fremont, ca, aug. 30, 2021 (globe newswire) -- via newmediawire – abvc biopharma, inc. (nasdaq: abvc), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today announced that zacks small cap research has issued an update report on the company which may be accessed at:
ABVC Ratings Summary
ABVC Quant Ranking